MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hjh.0000000000004304

Медицинская библиотека · Journal of hypertension · 2026

Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.

Preston Richard A, Caizapanta Evelyn V, Afshartous David, Chaparro Langely, Bueno Pamella A M, Jimenez Gisselle, Rubin Phillip, Bernstein Jeffrey N

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Severe hypertension without associated hypertensive target organ injury is termed hypertensive urgency. Treatment guidelines for the initial 4-6 hours uniformly warn against extreme (e.g. >80 mmHg) reduction in SBP and reduction more than 25% below baseline mean arterial pressure (MAP), the approximate lower limit of cerebral autoregulation. We hypothesized that rapid-acting antihypertensive regimens commonly employed for hypertensive urgency can reduce SBP and MAP in excess of these limits, potentially compromising cerebral blood flow.

METHODS

Retrospective cohort study in 1553 patients with hypertensive urgency to assess 5-hour SBP and MAP responses to the most commonly administered single-drug regimens ( n  = 453), combined single-drug and multiple-drug regimens ( n  = 1051), and no drug ( n  = 199). Co-primary endpoints: number (%) SBP reduction greater than 80 mmHg and number (%) MAP reduction more than 25%.

RESULTS SINGLEDOSE: rapid-acting oral clonidine ( n  = 214), intravenous hydralazine ( n  = 93), and intravenous labetalol ( n  = 40), produced 5-hour SBP reduction of more than 80 mmHg in 38/214 (18%), 17/93 (18%), and 8/40 (20%) patients, respectively, and MAP reduction of more than 25% in 98/214 (46%), 41/93 (44%), and 15/40 (38%) patients, respectively. Conversely, oral extended-release nifedipine ( n  = 84) and oral lisinopril ( n  = 22) produced SBP reduction of more than 80 mmHg in 1/84 (1%) and 1/22 (5%) patients. MAP reductions of more than 25% were also fewer: 18/84 (21%) and 2/22 (9%) patients.Combined single-drug/multidrug combinations ( n  = 1051) and no drug ( n  = 199) demonstrated similar excessive SBP and MAP reductions.

DISCUSSION: Our results demonstrate frequent extreme SBP and MAP reductions exceeding safety and autoregulatory limits with rapid-acting antihypertensives and the crucial need to develop and test novel clinical algorithms for the well tolerated and effective management of hypertensive urgency.

Для цитирования: Preston Richard A, Caizapanta Evelyn V, Afshartous David, Chaparro Langely, Bueno Pamella A M, Jimenez Gisselle, Rubin Phillip, Bernstein Jeffrey N. Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.. Journal of hypertension. 2026. DOI: 10.1097/hjh.0000000000004304.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.